Fabian Trillsch

Universität Hamburg

Papers

4

Total Citations

152

H-Index

4

About

Fabian Trillsch is a gynecologic oncologist whose research has made significant contributions to the understanding and clinical management of borderline ovarian tumors (BOT). Working prominently within the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT study framework, Trillsch has helped shape evidence-based approaches to one of gynecologic oncology's more nuanced diagnoses. His most-cited work, garnering 75 citations, revealed critical age-dependent differences in BOT patients' clinical characteristics and outcomes, offering clinicians a more refined prognostic lens. Complementing this, his research on surgical staging demonstrated that incomplete staging represents a meaningful negative prognostic factor, guiding surgeons toward more thorough operative protocols. With over 24 citations, his investigation into perioperative morbidity highlighted the delicate balance between surgical thoroughness and patient safety in a population with generally favorable prognoses. Notably, Trillsch has also extended his inquiry beyond survival metrics, examining quality of life and sexual function in BOT patients — an often-overlooked dimension of oncologic care. Collectively, his work reflects a comprehensive, patient-centered approach to gynecologic oncology, grounding clinical decision-making in robust multicenter data.

Research Focus

Key Achievements

4
H-Index
4
Papers
152
Total Citations
38
Avg Citations/Paper
🏆 Most Cited Paper
Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT study
75 citations · 2014
📈 Most Prolific Year: 2014 (2 Papers)
🤝 Key Collaborators: 46
🏛 Institutions: Universität Hamburg

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago